Medchem (P.R.), Inc. v. Commissioner, 295 F.3d 118, 1st Cir. (2002)
High-throughput fragment screening by WAC™€¢ X-ray co-crystallization • Medchem fragment...
Transcript of High-throughput fragment screening by WAC™€¢ X-ray co-crystallization • Medchem fragment...
WAC™! NMR! SPR! TS!Throughput ++ + ++ ++ Info Content ++ ++ + - Quality Control ++ ++ - - Cost efficiency ++ - - ++
Principles of WAC™ • Target protein immobilized on HPLC
column • Physiological buffer as mobile phase • Detection by LC-MS • Retention time of fragments related to
selective interactions with target • Kd calculated from retention time • Allows simultaneous identification of
weak binders (mM) in complex mixtures
Advantages of WAC™ WAC has significant advantages compared to the other methods in terms of speed and information provided.
WAC™ fragment screening is now an integral part of our FBLD services which also includes: • NMR screening/validation • X-ray co-crystallization • Medchem fragment expansion/elaboration • In vitro biology/ADME
We operate under an exclusive license of the proprietary WAC™ technology and offer this as a unique service
Contact info Red Glead Discovery AB | SARomics Biostructures AB
Medicon Village, SE-223 81 Lund, SWEDEN www.redglead.com | www.saromics.com
RED GLEAD DISCOVERY
High-throughput fragment screening by WAC™
Schematic representation of WAC™